Recently, an increase in SOCE, related to the up‐regulation of Stim1, Orai1 or TRPC1 expressions, has been observed in several different kinds of tumours 6, 24, 30, indicating SOCs are the potential therapeutic target for treatment of cancers. The gene discussed is TRPC1; the disease is neoplasm.